Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.
- 1 September 1991
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 84 (3) , 1040-1048
- https://doi.org/10.1161/01.cir.84.3.1040
Abstract
BACKGROUND We tested the hypothesis that beta-adrenergic receptor-stimulated acceleration of left ventricular (LV) isovolumic relaxation (i.e., positive lusitropic response) is attenuated in patients with severe congestive heart failure (CHF) compared with patients without LV dysfunction or CHF. METHODS AND RESULTS The beta-adrenergic agonist dobutamine was infused by the intracoronary route in 14 subjects (normal group, six; CHF patients, eight) and by the intravenous route in a second group of 14 subjects (normal group, four; CHF patients, 10). The positive inotropic response to intracoronary or intravenous dobutamine was substantially and significantly reduced in the patients with CHF. LV isovolumic relaxation rate was determined by the methods of Weiss (TL), Mirsky (T1/2), and by a nonlinear regression technique (TNL). LV isovolumic relaxation assessed by all three methods was significantly prolonged in CHF patients compared with normal subjects. Intracoronary and intravenous infusions of dobutamine caused significant acceleration of LV isovolumic relaxation in both normal subjects and patients with CHF. The magnitude of the dobutamine-stimulated acceleration of isovolumic relaxation in patients with CHF was comparable with that in normal subjects. CONCLUSIONS These data demonstrate that beta-adrenergic receptor stimulation causes significant acceleration of LV isovolumic relaxation in both normal subjects and patients with severe CHF. Coronary to our hypothesis, the lusitropic response to beta-adrenergic stimulation is well preserved in patients with severe CHF despite substantial attenuation of the beta-adrenergic positive inotropic response. These findings have potentially important implications regarding the physiology and pharmacology of adrenergically mediated LV relaxation in humans.Keywords
This publication has 16 references indexed in Scilit:
- Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.Journal of Clinical Investigation, 1990
- Distribution and function of human ventricular beta adrenergic receptors in congestive heart failureJournal of Molecular and Cellular Cardiology, 1989
- Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.Journal of Clinical Investigation, 1988
- Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.Journal of Clinical Investigation, 1988
- Cyclic adenosine monophosphate effects on the myocardium: A man who blows hot and cold with one breathJournal of the American College of Cardiology, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heartNature, 1982
- Alterations in left ventricular relaxation and diastolic compliance in congestive cardiomyopathyCardiovascular Research, 1979
- Pharmacologic and Hemodynamic Influences on the Rate of Isovolumic Left Ventricular Relaxation in the Normal Conscious DogJournal of Clinical Investigation, 1977
- Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.Journal of Clinical Investigation, 1976